Session information

Tweet

Session1-8

Lecture

[07] Session-3: Risk Assessment, Management of patients with germline mutations

Sat. Jan 23, 2021 6:00 PM - 8:30 PM ROOM1 (Japan Standard Time)

Start: 18:00(JST) / 10:00(CET) / 3:00(CST)

+Add all to schedule

[Z07] Join the ZOOMWebinar [Session3]

Closed.
If you would like to watch the Day1 Lecture,
please go to the page below.
https://confit.atlas.jp/guide/event/kbccc2021/static/Day1Lecture

Introduction (6:00 PM - 6:05 PM)

6:05 PM - 6:30 PM

[1L16] Prediction tools to identify high-risk individuals

*Masahiro Takada¹ (1. Kyoto University)

6:30 PM - 6:55 PM

[1L18] Should all newly diagnosed breast cancer patients have genetic testing

*Stephen Grobmyer¹ (1. Cleveland Clinic Abu Dhabi)

6:55 PM - 7:20 PM

[1L19] Prevention of cancer development for women having pathogenic variants of hereditary breast cancer

*Hideko Yamauchi¹ (1. St. Luke's International Hospital)

Voting and discussion (7:20 PM - 8:00 PM)